Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Kaifang Zou"'
Publikováno v:
Energies, Vol 17, Iss 15, p 3692 (2024)
Colleges and universities are large consumers of energy, with a huge potential for building energy efficiency, and need to reduce energy consumption to build a low-carbon, energy-saving campus. Predicting the energy consumption of campus buildings ca
Externí odkaz:
https://doaj.org/article/4301952b133b4f05bbb724efcb48d6db
Autor:
Hong Yang, Kaichun Wu, Hongjie Zhang, Qin Owyang, Yinglei Miao, Fang Gu, Naizhong Hu, Kaifang Zou, Jianqiu Sheng, Jin Li, Ping Zheng, Yulan Liu, Junxia Li, Xiaodi Wang, Yongdong Wu, Yaozong Yuan, Chunxiao Chen, Yanhua Pang, Meihua Cui, Jiaming Qian
Publikováno v:
BMC Gastroenterology, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Cytomegalovirus (CMV) infection can significantly complicate and worsen the condition of acute severe ulcerative colitis (UC) patients. We aimed to explore the predictive risk factors to prevent and identify CMV infection at an ea
Externí odkaz:
https://doaj.org/article/e2aa1e642aec4349b2b5ffee7c02abc1
Publikováno v:
BMC Gastroenterology, Vol 19, Iss 1, Pp 1-5 (2019)
Abstract Background Mesalamine is a first-line drug in the treatment of inflammatory bowel diseases, while its intolerance occasionally occurs in clinical practice. Most of adverse reactions are due to the active components, which may lead to step-up
Externí odkaz:
https://doaj.org/article/685728c123b74d248adf2a7bf5e1f3bf
Autor:
Di Guo, Jun Yang, Fangmei Ling, Lei Tu, Junrong Li, Yidong Chen, Kaifang Zou, Liangru Zhu, Xiaohua Hou
Publikováno v:
Journal of Immunology Research, Vol 2020 (2020)
Background. Clinical data suggest that enteral nutrition (EN) effectively decreases disease activity and maintains remission in patients with inflammatory bowel disease (IBD). However, the modulatory effects of EN on the intestinal mucosal immune sys
Externí odkaz:
https://doaj.org/article/2515cc0583cc45ab97aa9033619ebbc1
Autor:
Huan Wang, Lei Tu, Ying Li, Tao Bai, Kaifang Zou, Fang Xiao, Jin Li, Min Chen, Heng Zhang, Gangqin Li, Yueyue Lu, Kai Wang, Shu Jin, Yuanping Yang, Liangru Zhu, Xiaohua Hou
Publikováno v:
Journal of Immunology Research, Vol 2020 (2020)
Objectives. The COVID-19 epidemic triggered by coronavirus SARS-CoV-2 is rapidly spreading around the globe. This study is aimed at finding out the suspected or confirmed SARS-CoV-2 infection in patients with inflammatory bowel disease (IBD) in Hubei
Externí odkaz:
https://doaj.org/article/1eeef6ceb85641b68f8ed01c8d46b746
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
Abstract Faecal calprotectin and faecal occult blood test (FOBT) were widely used in the diagnosis and assessment of intestinal inflammation in inflammatory bowel disease (IBD). Recently we identified an excellent new biomarker B cell-activating fact
Externí odkaz:
https://doaj.org/article/ab8f91a293674f85b359a1e55fa01806
Publikováno v:
Digestive Diseases and Sciences. 67:4749-4759
Intestinal fibrosis is the most common complication of inflammatory bowel disease; nevertheless, specific therapies are still unavailable. Resolvin D1 (RvD1), a typical endogenous ω-3 fatty acid-derived lipid mediator, has attracted wide attention d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::736c01a4a4906d3212434418ec4389b1
https://doi.org/10.1007/s10620-021-07356-w
https://doi.org/10.1007/s10620-021-07356-w
Autor:
Kaifang Zou, Min Chen, Kai Wang, Ying Li, Shu Jin, Huan Wang, Lei Tu, Liangru Zhu, Gangqin Li, Jin Li, Heng Zhang, Fang Xiao, Xiaohua Hou, Tao Bai, Yuanping Yang, Yueyue Lu
Publikováno v:
Journal of Immunology Research, Vol 2020 (2020)
Journal of Immunology Research
Journal of Immunology Research
Objectives The COVID-19 epidemic triggered by coronavirus SARS-CoV-2 is rapidly spreading around the globe This study is aimed at finding out the suspected or confirmed SARS-CoV-2 infection in patients with inflammatory bowel disease (IBD) in Hubei p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c55a6bf3a1e29b1f63e1f0f929a0aa15
https://doi.org/10.1155/2020/2847316
https://doi.org/10.1155/2020/2847316
Autor:
Jun Yang, Liangru Zhu, Yidong Chen, Xiaohua Hou, Junrong Li, Lei Tu, Kaifang Zou, Di Guo, Fangmei Ling
Publikováno v:
Journal of Immunology Research, Vol 2020 (2020)
Journal of Immunology Research
Journal of Immunology Research
Background. Clinical data suggest that enteral nutrition (EN) effectively decreases disease activity and maintains remission in patients with inflammatory bowel disease (IBD). However, the modulatory effects of EN on the intestinal mucosal immune sys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bd460f5f767ca8fb82d68f2226d613f
https://doi.org/10.1155/2020/9430763
https://doi.org/10.1155/2020/9430763
Publikováno v:
BMC Gastroenterology, Vol 19, Iss 1, Pp 1-5 (2019)
BMC Gastroenterology
BMC Gastroenterology
Background Mesalamine is a first-line drug in the treatment of inflammatory bowel diseases, while its intolerance occasionally occurs in clinical practice. Most of adverse reactions are due to the active components, which may lead to step-up treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18e7910e491e860244afeee2a5b1b245
http://link.springer.com/article/10.1186/s12876-019-1049-2
http://link.springer.com/article/10.1186/s12876-019-1049-2